Literature DB >> 12205736

The roles of stromelysin-1 and the gelatinase B gene polymorphism in stable angina.

Jung-Sun Kim1, Hyun-Young Park, Jun Hye Kwon, Eun Kyung Im, Dong Hoon Choi, Yang Soo Jang, Seung-Yun Cho.   

Abstract

Matrix metalloproteinases contribute to vascular remodeling by breaking down extracellular-matrix while new matrix is synthesized. Of the variety of MMPs, stromelysin-1 and gelatinase B may have key roles in coronary artery atherosclerosis. Moreover, The 5A/6A polymorphism in the promoter region of the stromelysin-1 gene may be a pathogenetic risk factor for acute myocardial infarction. Gelatinase B (92-kDa type IV collagenase and MMP-9) is one of the MMPs found to be highly expressed in the disruption-prone regions of atherosclerotic plaques. C- to T substitution at the promoter site (-1562) resulted in the higher promoter activity of the T-allelic promoter. The R279Q polymorphism in exon 6 led to the substitution of adenosine by guanine, and was a common polymorphism in the general population. We evaluated the relation between these polymorphisms and stable angina, the severity of atherosclerosis in coronary artery disease, and in-stent restenosis after percutaneous coronary angioplasty. The study population was composed of 131 patients with stable angina (mean age 61.3 years, 89 males) and 117 control subjects (mean age 59.3 years, 59 males). Coronary angiographies were performed in all cases at Yonsei University Cardiovascular Hospital from February 1998 to June 2000. The genotype for each polymorphism was determined using a SNaPshotTM kit and by restriction fragment length polymorphism (RFLP). The prevalence of 5A containing a polymorphism of the stromelysin-1 gene was higher in the stable angina group than in control patients, but no difference in the two polymorphisms of the gelatinase B gene was found between the two groups. By multiple logistic analysis, the 5A-allele of the stromelysin-1 gene was found to be an independent risk factor of stable angina with an odds ratio of 2.29 (95% CI; 1.19-4.38). However, the severity of atherosclerosis in coronary artery or in stent restenosis was not related to any polymorphism of stromelysin-1 or gelatinase B. Our results show that functional genetic variation of stromelysin-1 could be a significant risk factor for stable angina, and might play an important role in coronary atherosclerosis involving vascular remodeling.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12205736     DOI: 10.3349/ymj.2002.43.4.473

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


  15 in total

1.  Genetic variation in matrix metalloproteinase MMP2 and MMP9 as a risk factor for idiopathic recurrent spontaneous abortions in an Indian population.

Authors:  Deepika Ramu; Vettriselvi Venkatesan; Solomon Franklin Durairaj Paul; Teena Koshy
Journal:  J Assist Reprod Genet       Date:  2017-05-12       Impact factor: 3.412

Review 2.  The role of genetic variants of matrix metalloproteinases in coronary and carotid atherosclerosis.

Authors:  Sonia Abilleira; Steve Bevan; Hugh S Markus
Journal:  J Med Genet       Date:  2006-08-11       Impact factor: 6.318

3.  Association of MMP-9 gene polymorphisms with nephrolithiasis patients.

Authors:  Atheer Awad Mehde; Wesen Adel Mehdi; Faridah Yusof; Raha Ahmed Raus; Zaima Azira Zainal Abidin; Hamid Ghazali; Azlina Abd Rahman
Journal:  J Clin Lab Anal       Date:  2017-02-15       Impact factor: 2.352

4.  Matrix metalloproteinase-3 (MMP3) and MMP9 genes and risk of myocardial infarction, ischemic stroke, and hemorrhagic stroke.

Authors:  Robert C Kaplan; Nicholas L Smith; Stanley Zucker; Susan R Heckbert; Kenneth Rice; Bruce M Psaty
Journal:  Atherosclerosis       Date:  2008-03-14       Impact factor: 5.162

5.  Functional polymorphisms of matrix metallopeptidase-9 and risk of coronary artery disease in a Chinese population.

Authors:  Hong Zhi; Hua Wang; Liqun Ren; Zhiyang Shi; Haiyan Peng; Lunbiao Cui; Genshan Ma; Xingzhou Ye; Yi Feng; Chengxing Shen; Xiangjun Zhai; Chenyu Zhang; Ke Zen; Naifeng Liu
Journal:  Mol Biol Rep       Date:  2009-03-13       Impact factor: 2.316

6.  Risk of coronary artery stenosis in Iranian type 2 diabetics: is there a role for matrix metalloproteinase-3 gene (-1612 5A/6A) polymorphism?

Authors:  Soudabeh Fallah; Morteza Seifi; Ali Samadikuchaksaraei
Journal:  J Physiol Biochem       Date:  2010-08-26       Impact factor: 4.158

7.  Association of MMP-9 gene polymorphisms with acute coronary syndrome in the Uygur population of China.

Authors:  Lei Wang; Yi-Tong Ma; Xiang Xie; Yi-Ning Yang; Zhen-Yan Fu; Fen Liu; Xiao-Mei Li; Bang-Dang Chen
Journal:  World J Emerg Med       Date:  2011

8.  Matrix metalloproteinase-3 (MMP-3) -1612 5A/6A promoter polymorphism in coronary artery disease in Indian population.

Authors:  Kavita K Shalia; V K Shah; M R Mashru; S L Soneji; J B Vasvani; S Payannavar; A Walvalkar; R Mokal; S S Mithbawkar; M Bootwalla; P Sadvekar; P K Thakur
Journal:  Indian J Clin Biochem       Date:  2010-05-27

Review 9.  Association of matrix metalloproteinase-9 C1562T polymorphism and coronary artery disease: a meta-analysis.

Authors:  Xiao Wang; Lei-zhi Shi
Journal:  J Zhejiang Univ Sci B       Date:  2014-03       Impact factor: 3.066

10.  Polymorphism of matrix metalloproteinase-3 promoter gene as a risk factor for coronary artery lesions in Kawasaki disease.

Authors:  Jeong-Ah Park; Kyung-Sue Shin; Youn Woo Kim
Journal:  J Korean Med Sci       Date:  2005-08       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.